Genome-wide interaction study of smoking and bladder cancer risk
- PMID: 24662972
- PMCID: PMC4123644
- DOI: 10.1093/carcin/bgu064
Genome-wide interaction study of smoking and bladder cancer risk
Abstract
Bladder cancer is a complex disease with known environmental and genetic risk factors. We performed a genome-wide interaction study (GWAS) of smoking and bladder cancer risk based on primary scan data from 3002 cases and 4411 controls from the National Cancer Institute Bladder Cancer GWAS. Alternative methods were used to evaluate both additive and multiplicative interactions between individual single nucleotide polymorphisms (SNPs) and smoking exposure. SNPs with interaction P values < 5 × 10(-) (5) were evaluated further in an independent dataset of 2422 bladder cancer cases and 5751 controls. We identified 10 SNPs that showed association in a consistent manner with the initial dataset and in the combined dataset, providing evidence of interaction with tobacco use. Further, two of these novel SNPs showed strong evidence of association with bladder cancer in tobacco use subgroups that approached genome-wide significance. Specifically, rs1711973 (FOXF2) on 6p25.3 was a susceptibility SNP for never smokers [combined odds ratio (OR) = 1.34, 95% confidence interval (CI) = 1.20-1.50, P value = 5.18 × 10(-) (7)]; and rs12216499 (RSPH3-TAGAP-EZR) on 6q25.3 was a susceptibility SNP for ever smokers (combined OR = 0.75, 95% CI = 0.67-0.84, P value = 6.35 × 10(-) (7)). In our analysis of smoking and bladder cancer, the tests for multiplicative interaction seemed to more commonly identify susceptibility loci with associations in never smokers, whereas the additive interaction analysis identified more loci with associations among smokers-including the known smoking and NAT2 acetylation interaction. Our findings provide additional evidence of gene-environment interactions for tobacco and bladder cancer.
Published by Oxford University Press 2014.
Figures
References
-
- Silverman D.T., et al. (2006). Bladder cancer. In Fraumeni J.F., Jr, Schottenfeld D. (eds) Cancer Epidemiology and Prevention Third Edition. Oxford University Press, New York, NY, pp. 1101–1127
Publication types
MeSH terms
Substances
Grants and funding
- U01HG004446/HG/NHGRI NIH HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- CA34627/CA/NCI NIH HHS/United States
- UM1 CA176726/CA/NCI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- NCI N02-CP-01037/CP/NCI NIH HHS/United States
- R01CA65726/CA/NCI NIH HHS/United States
- R01CA114665/CA/NCI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- R01 CA057494/CA/NCI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- 16491/CRUK_/Cancer Research UK/United Kingdom
- U01HG004438/HG/NHGRI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U01 HG004446/HG/NHGRI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA67262/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- BHF_/British Heart Foundation/United Kingdom
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- R01 CA065726/CA/NCI NIH HHS/United States
- N02 CP001037/CP/NCI NIH HHS/United States
- N02 CP011015/CP/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- R01-CA089715/CA/NCI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- R01 CA089715/CA/NCI NIH HHS/United States
- R01 CA49449/CA/NCI NIH HHS/United States
- R01 CA114665/CA/NCI NIH HHS/United States
- HHSN268200782096C/HG/NHGRI NIH HHS/United States
- 1P01CA86871/CA/NCI NIH HHS/United States
- MRC_/Medical Research Council/United Kingdom
- HHSN271201100004C/AG/NIA NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- NCI N02-CP-11015/CP/NCI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- R01HL091172-01/HL/NHLBI NIH HHS/United States
- P01 CA086871/CA/NCI NIH HHS/United States
- R01 CA034627/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- CA055075/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
- HHSN268201100001C/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
